Cadila gets 5 observations from USFDA for subsidiary#39;s injectables facility

Cadila gets 5 observations from USFDA for subsidiary#39;s injectables facility United States Food and Drug Administration (USFDA) conducted the inspection from August 20-28. Liva is a 100 percent subsidiary of Cadila Healthcare.

No comments:

Post a Comment